These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29098384)

  • 61. Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.
    Butte JM; Gönen M; Allen PJ; Peter Kingham T; Sofocleous CT; DeMatteo RP; Fong Y; Kemeny NE; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2015 Aug; 22(8):2761-71. PubMed ID: 25572686
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.
    Andreou A; Aloia TA; Brouquet A; Dickson PV; Zimmitti G; Maru DM; Kopetz S; Loyer EM; Curley SA; Abdalla EK; Vauthey JN
    Ann Surg; 2013 Jun; 257(6):1079-88. PubMed ID: 23426338
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
    Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
    Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.
    Ardito F; Panettieri E; Vellone M; Ferrucci M; Coppola A; Silvestrini N; Arena V; Adducci E; Capelli G; Vecchio FM; Giovannini I; Nuzzo G; Giuliante F
    Surgery; 2019 Apr; 165(4):712-720. PubMed ID: 30482518
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preoperative Chemotherapy May Not Influence the Remnant Liver Regenerations and Outcomes After Hepatectomy for Colorectal Liver Metastasis.
    Inoue Y; Fujii K; Tashiro K; Ishii M; Masubuchi S; Yamamoto M; Shimizu T; Asakuma M; Hirokawa F; Hayashi M; Narumi Y; Uchiyama K
    World J Surg; 2018 Oct; 42(10):3316-3330. PubMed ID: 29549511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases: A Propensity Score Matching Analysis.
    Memeo R; de Blasi V; Adam R; Goéré D; Piardi T; Lermite E; Turrini O; Navarro F; de'Angelis N; Cunha AS; Pessaux P;
    World J Surg; 2018 Mar; 42(3):892-901. PubMed ID: 28929341
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases.
    Neeff HP; Drognitz O; Klock A; Illerhaus G; Opitz OG; Hopt UT; Makowiec F
    Int J Colorectal Dis; 2012 May; 27(5):635-45. PubMed ID: 22139030
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
    Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
    ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.
    Weiss MJ; Ito H; Araujo RL; Zabor EC; Gonen M; D'Angelica MI; Allen PJ; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg Oncol; 2013 Jan; 20(1):285-94. PubMed ID: 22868921
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 'Close shave' in liver resection for colorectal liver metastases.
    Lordan JT; Karanjia ND
    Eur J Surg Oncol; 2010 Jan; 36(1):47-51. PubMed ID: 19502001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Importance of resection margin after resection of colorectal liver metastases in the era of modern chemotherapy: population-based cohort study.
    Östrand E; Rystedt J; Engstrand J; Frühling P; Hemmingsson O; Sandström P; Sternby Eilard M; Tingstedt B; Buchwald P
    BJS Open; 2024 May; 8(3):. PubMed ID: 38717909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study.
    Karanjia ND; Lordan JT; Fawcett WJ; Quiney N; Worthington TR
    Eur J Surg Oncol; 2009 Aug; 35(8):838-43. PubMed ID: 19010633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
    J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
    Moris D; Ronnekleiv-Kelly S; Rahnemai-Azar AA; Felekouras E; Dillhoff M; Schmidt C; Pawlik TM
    J Gastrointest Surg; 2017 Jun; 21(6):1076-1085. PubMed ID: 28364212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.